FDA Warns of Name Confusion Risks with Kadcyla and Herceptin
Confusion between the names of two popular breast cancer drugs may cause serious medical errors, according to a warning issued by federal health officials.
Confusion between the names of two popular breast cancer drugs may cause serious medical errors, according to a warning issued by federal health officials.